TL;DR — Key Takeaways

• Adding a physician partner to a California medical corporation requires updating the corporate share structure, the shareholders’ agreement, and any governance documents.
• Equity buy-in is typically priced based on a valuation of the practice. Common methods include book value, capitalized earnings, multiple of EBITDA, or a hybrid.
• Only licensed physicians (and a narrow list of other healthcare licensees as minority shareholders) can hold equity in a California medical corporation under BPC § 13401.5.
• A buy-sell agreement or shareholder agreement governs what happens if the partner leaves, dies, becomes disabled, or is dismissed. Not having one creates predictable disputes.
• Buy-in transactions can have tax consequences for both the existing shareholders and the incoming partner. Coordinate with a CPA before signing.

What Is Required to Add a Physician as a Shareholder in a California Medical Corporation?

Three categories of work are required: regulatory, corporate, and contractual.

Regulatory. The new shareholder must hold an active California physician license (MD or DO) in good standing. The PC’s professional corporation status with the Secretary of State and the Medical Board’s registration must reflect the addition. Fictitious name permits, payer enrollments, and DEA registrations may need to be updated.

Corporate. The PC issues new shares (or transfers existing shares from current shareholders) to the new partner. The corporate share register, stock certificates, and ownership records are updated. The board of directors and any officer positions are updated if the new partner takes a board or officer role.

Contractual. A shareholders’ agreement (or buy-sell agreement) is amended or executed to include the new partner. Employment agreements are signed. Compensation, governance rights, and restrictive covenants (where enforceable) are documented.

Any partner addition that skips one of these categories creates problems that surface later — often when the partner leaves, dies, or has a dispute with the other shareholders.

How Is Physician Buy-In Equity Priced in a Medical Practice?

Buy-in pricing varies dramatically based on the practice’s profitability, specialty, location, and the deal structure. Common methodologies include:

Book value (modified). The practice’s tangible assets (equipment, furniture, accounts receivable, cash) less liabilities. Modified book value adjusts for depreciation and discounts AR. Often used for buy-ins that are intended to be modest, with an emphasis on partnership rather than capital extraction.

Capitalized earnings. Annual earnings (typically the partner’s pro-rata share of practice net income) divided by a capitalization rate. Capitalization rates of 15%-25% are common for medical practices, reflecting expected return.

Multiple of EBITDA. Earnings before interest, taxes, depreciation, and amortization, multiplied by an industry multiple. For physician practices, multiples have varied widely; specialty practices have transacted at 4x-8x EBITDA in recent years, depending on market conditions and PE activity. [VERIFY: confirm current market context.]

Hybrid / formula. Many practices use a blended approach or a fixed formula in the shareholders’ agreement that establishes the buy-in price for new partners.

The buy-in is typically funded by the new partner directly, by a bank loan to the partner, or by deferred payment over several years through a promissory note paid out of practice distributions or salary reductions.

What Governance Documents Need to Be Updated When Adding a Partner?

Several documents require attention.

Articles of incorporation and bylaws. Usually do not require amendment unless the share structure or class of stock is changing. The bylaws may need updating if the new partner takes a board seat.

Shareholders’ agreement / buy-sell agreement. This is the most important document. It governs the relationship among shareholders, including buy-in pricing for future partners, mandatory and optional buyout triggers (death, disability, retirement, dismissal, divorce), valuation methodology for buyouts, voting rights, and restrictions on transfer.

Employment agreement. The new partner’s employment terms — compensation, benefits, scope of duties, term, termination provisions, post-employment obligations.

Stock purchase agreement. The transactional document for the buy-in itself, addressing purchase price, payment terms, representations, and conditions.

Compensation plan. Practices typically have a written compensation plan that allocates revenue and expenses among partners. The plan should address how the new partner enters the formula.

Insurance updates. Malpractice tail coverage for any prior employer practice, and updated practice malpractice and employment practices coverage to reflect the new partner.

Can a New Physician Partner Be Added Without Restructuring the Entire Corporation?

Yes, in most cases. Adding a partner usually involves issuing new shares or transferring existing shares, not restructuring the entity itself.

The simpler approach is a stock issuance: the PC issues new shares to the incoming partner in exchange for the buy-in payment. This dilutes existing shareholders proportionally based on the new ownership percentages.

The alternative is a stock transfer: existing shareholders sell some of their shares to the new partner. This concentrates the buy-in proceeds among the selling shareholders and avoids dilution of any non-selling shareholders.

The two approaches have different tax consequences. Stock issuance is generally a contribution to the corporation (the PC receives the buy-in funds, which can be used for distributions or operations). Stock transfer is a sale by individual shareholders (the selling shareholders receive the buy-in funds and pay capital gains tax on the gain). Coordinate with a tax advisor before deciding.

What Happens if a Physician Shareholder Wants to Leave After Buying In?

The shareholders’ agreement controls. A well-drafted agreement addresses departure scenarios in advance, eliminating most of the uncertainty.

Voluntary departure. The agreement typically requires the departing partner to sell their shares back to the corporation or remaining shareholders at a price determined by a formula (often book value or a discount to fair market value). Payment terms, non-competition (where enforceable under BPC § 16601 sale-of-business), and tail malpractice coverage are addressed.

Involuntary departure (dismissal for cause). Usually triggers a buyout at a discount. Definitions of cause should be clear and narrow.

Death or disability. Triggers a mandatory buyout, often funded through life insurance or disability insurance held by the corporation on each partner.

Retirement. Some agreements have specific retirement provisions, including buyouts paid over a longer period and continued benefits for retired partners.

Practices without a buy-sell agreement face the worst version of partner departures. The departing partner can demand a forced sale or appraisal, the remaining partners may not have funding to buy them out, and the dispute can paralyze the practice.

Tax and Compensation Considerations

Adding a partner is a taxable event. The corporation, the existing shareholders, and the new partner all have potential tax considerations.

For the new partner. The buy-in is a capital investment, not deductible as an expense. If financed, interest may be deductible against future practice income subject to limits.

For selling shareholders (in a transfer transaction). Sale of shares is a capital gain event, taxed at the shareholder’s capital gains rate.

For the corporation. A stock issuance to a new partner generates capital that flows into the entity, no immediate tax impact on the corporation itself.

Compensation realignment. The compensation plan should be reviewed to make sure the new partner’s compensation structure makes sense relative to existing partners. Common issues: production-based vs. salary, allocation of overhead, treatment of ancillary income.

Estate and personal planning. A new partner has new estate planning needs related to their practice equity. The shareholders’ agreement should address what happens on the partner’s death and how their equity passes.

This article is for general information and is not legal advice. For guidance on your specific situation, contact Bay Legal, PC at 650-668-8000 to schedule a consultation.